Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

C16orf48_E130303B06Rik Inhibitors

PI3K, JNK, p38 MAPK, and MEK, thereby affecting phosphorylation events that can regulate protein activity, localization, and protein-protein interactions. Inhibitors like Staurosporine, LY294002, SP600125, SB203580, U0126, and PD98059 fall into this category, each with the capacity to disrupt specific kinase signaling cascades that may be crucial for the function of C16orf48_E130303B06Rik.

Further more these chemicals that intervene in protein synthesis and degradation pathways, such as Rapamycin and MG132. Rapamycin's inhibition of mTOR can affect the translation of proteins, influencing cellular growth and metabolism, while MG132's proteasome inhibition can lead to the accumulation of proteins, impacting protein turnover and signaling. Cyclopamine's inhibition of the Hedgehog pathway and ZM-447439's disruption of Aurora kinase activity exemplify inhibitors that can affect developmental pathways and cell division, respectively, which are essential processes in cellular function and homeostasis. Gefitinib's role in EGFR inhibition can impact cell proliferation and apoptosis, while Y-27632 can affect cell structure and motility through its action on the ROCK pathway.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

A MEK inhibitor similar to U0126, which can prevent the activation of ERK and thereby affect the function of proteins within the MAPK/ERK pathway.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

A ROCK inhibitor that can affect cytoskeleton dynamics and cell motility, potentially influencing the function of proteins related to these processes.